83 FR 64365 - Importer of Controlled Substances Application: Usona Institute
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 240 (December 14, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 240 (December 14, 2018)
| Page Range | 64365-64365 | |
| FR Document | 2018-27133 |
[Federal Register Volume 83, Number 240 (Friday, December 14, 2018)] [Notices] [Page 64365] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-27133] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Usona Institute ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 14, 2019. Such persons may also file a written request for a hearing on the application on or before January 14, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on October 31, 2018, Usona Institute, 2800 Woods Hollow Road, Madison, Wisconsin 53711 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ 5-Methoxy-N-N-dimethyltryptamine......... 7431 I Dimethyltryptamine....................... 7435 I ------------------------------------------------------------------------ The institute plans to import the listed controlled substances for potential formulation development for substances to be used in institute-sponsored research. Dated: December 4, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-27133 Filed 12-13-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices 64365
958, to the DEA Administrator, 28 CFR and may, at the same time, file a written Administration, Attn: Administrator,
0.100(b). Authority to exercise all request for a hearing. Any such 8701 Morrissette Drive, Springfield,
necessary functions with respect to the comments, objections, or hearing Virginia 22152. All requests for hearing
promulgation and implementation of 21 requests should be addressed as should also be sent to: (1) Drug
CFR part 1301, incident to the described above. Enforcement Administration, Attn:
registration of manufacturers, Dated: December 4, 2018. Hearing Clerk/OALJ, 8701 Morrissette
distributors, dispensers, importers, and Drive, Springfield, Virginia 22152; and
John J. Martin,
exporters of controlled substances (other (2) Drug Enforcement Administration,
Assistant Administrator.
than final orders in connection with Attn: DEA Federal Register
suspension, denial, or revocation of [FR Doc. 2018–27131 Filed 12–13–18; 8:45 am]
Representative/DPW, 8701 Morrissette
registration) has been delegated to the BILLING CODE 4410–09–P Drive, Springfield, Virginia 22152.
Assistant Administrator of the DEA
SUPPLEMENTARY INFORMATION: The
Diversion Control Division (‘‘Assistant
DEPARTMENT OF JUSTICE Attorney General has delegated his
Administrator’’) pursuant to section 7 of
authority under the Controlled
28 CFR part 0, appendix to subpart R. Drug Enforcement Administration
Therefore, in accordance with 21 Substances Act to the Administrator of
U.S.C. 958(i) and 21 CFR 1301.34(a), the Drug Enforcement Administration
[Docket No. DEA–392]
this is notice that on June 11, 2018, (DEA), 28 CFR 0.100(b). Authority to
Arizona Department of Corrections, Importer of Controlled Substances exercise all necessary functions with
1305 E Butte Avenue, ASPC-Florence, Application: Usona Institute respect to the promulgation and
Florence, Arizona 85132–9221, re- implementation of 21 CFR part 1301,
applied to be registered as an importer ACTION: Notice of application. incident to the registration of
of Pentobarbital (2270), a basic class of manufacturers, distributors, dispensers,
the controlled substance listed in DATES: Registered bulk manufacturers of importers, and exporters of controlled
schedule II. the affected basic classes, and substances (other than final orders in
The facility intends to import the applicants therefore, may file written connection with suspension, denial, or
above-listed controlled substance for comments on or objections to the revocation of registration) has been
legitimate use. This particular issuance of the proposed registration on redelegated to the Assistant
controlled substance is not available for or before January 14, 2019. Such Administrator of the DEA Diversion
the intended legitimate use within the persons may also file a written request Control Division (‘‘Assistant
current domestic supply of the United for a hearing on the application on or Administrator’’) pursuant to section 7 of
States. before January 14, 2019. 28 CFR part 0, appendix to subpart R.
Any bulk manufacturer who is ADDRESSES: Written comments should In accordance with 21 CFR
presently, or is applying to be, be sent to: Drug Enforcement 1301.34(a), this is notice that on October
registered with DEA to manufacture this Administration, Attention: DEA Federal 31, 2018, Usona Institute, 2800 Woods
basic class of controlled substance may Register Representative/DPW, 8701 Hollow Road, Madison, Wisconsin
file comments or objections to the Morrissette Drive, Springfield, Virginia 53711 applied to be registered as an
issuance of the proposed registration or 22152. All requests for hearing must be importer of the following basic classes
to the authorization of this importation, sent to: Drug Enforcement of controlled substances:
Controlled substance Drug code Schedule
5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. 7431 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
The institute plans to import the DEPARTMENT OF JUSTICE review and approval in accordance with
listed controlled substances for the Paperwork Reduction Act of 1995.
potential formulation development for OMB Number 1117–0008] DATES: Comments are encouraged and
substances to be used in institute- will be accepted for 60 days until
sponsored research. Agency Information Collection February 12, 2019.
Dated: December 4, 2018.
Activities; Proposed eCollection, FOR FURTHER INFORMATION CONTACT: If
eComments Requested; Extension you have comments, especially on the
John J. Martin,
Without Change of a Previously estimated public burden or associated
Assistant Administrator. Approved Collection; Application for response time, suggestions, or need a
[FR Doc. 2018–27133 Filed 12–13–18; 8:45 am] Procurement Quota for Controlled copy of the proposed information
BILLING CODE 4410–09–P Substance and for Ephedrine, collection instrument with instructions
Pseudoephedrine, and or additional information, please
Phenylpropanolamine; DEA Form 250 contact Kathy L. Federico, Diversion
AGENCY: Drug Enforcement Control Division, Drug Enforcement
Administration, Department of Justice. Administration; Mailing Address: 8701
amozie on DSK3GDR082PROD with NOTICES1
Morrissette Drive, Springfield, Virginia
ACTION: 60-Day Notice.
22152; Telephone: (202) 598–6812.
SUMMARY: The Department of Justice, SUPPLEMENTARY INFORMATION: Written
Drug Enforcement Administration comments and suggestions from the
(DEA), will be submitting the following public and affected agencies concerning
information collection request to the the proposed collection of information
Office of Management and Budget for are encouraged. Your comments should
VerDate Sep<11>2014 16:57 Dec 13, 2018 Jkt 247001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\14DEN1.SGM 14DEN1](https://thefederalregister.org/doc/83_FR_64605/page/1.svg)
Document Created: 2018-12-14 03:50:11
Document Modified: 2018-12-14 03:50:11
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 14, 2019. Such persons may also file a written request for a hearing on the application on or before January 14, 2019. | |
| FR Citation | 83 FR 64365 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR